USPTO issues new patent for CombiPlex technology platform: Celator Pharma
CombiPlex is an approach using drug carriers (nano-scale liposomes) to deliver synergistic ratios of drug combinations for the treatment of cancer. Celator Pharma claims that in contrast to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.